The Drug Development, Pharmacokinetics and Imaging module is a one-week module of the MSc in Experimental Therapeutics programme. Offered by the Department of Oncology and the Department for ...
Devyani Deshpande, Jotam G. Pasipanodya, Stellah G. Mpagama, Shashikant Srivastava, Paula Bendet, Thearith Koeuth, Pooi S. Lee, Scott K. Heysell, Tawanda Gumbo ...
Bingeing is one pattern of high-dose methamphetamine (METH) abuse, which involves continuous drug taking over several days and can result in psychotic behaviors for which the brain pathology remains ...
PURPOSE: To establish the safety and tolerability of ZD1839 (Iressa), a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and to explore its pharmacokinetic and ...
Mycophenolate mofetil (MMF, CellCept ®; Roche Laboratories, Nutley, NJ, USA) has been widely accepted as the antimetabolite immunosuppressant of choice in the immunosuppressive regimen of solid organ ...
In drug discovery trials, the potential for a molecule to do harm to an organism must be known accurately. Understanding how a substance under investigation behaves once in the body informs the design ...
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...
RICHMOND, Va.--(BUSINESS WIRE)--Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback